CNE100003308
CNE100003308
PHARSCIN PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 6.45B EUR | 5.54B EUR | 5.94B EUR |
Enterprise Value | 5.81B EUR | 5.28B EUR | 5.69B EUR |
Valuation Multiples | |||
Trailing P/E | 81.26x | 80.07x | 74.87x |
Forward P/E | -- | -- | -- |
Price to Sales | 8.07x | 6.78x | 6.95x |
Price to Book | 3.71x | 3.19x | 3.45x |
EV/Revenue | 7.28x | 6.46x | 6.65x |
EV/EBITDA | 39.86x | 75.35x | 64.29x |
Price to FCF (P/FCF) | 118.77x | 78.2x | 82.38x |
EV/FCF | 107.06x | 74.57x | 78.85x |
FCF Yield | 0.84% | 1.28% | 1.21% |